Combining Augmentin and Doxycycline for Respiratory Infections

Evidence from Clinical Guidelines

The British Thoracic Society and WHO guidelines recommend combining amoxicillin/clavulanate with doxycycline as a second-line option for moderate community-acquired pneumonia (CAP), particularly when beta-lactamase-producing Haemophilus influenzae is suspected 1, 2
The American Thoracic Society/IDSA guidelines support β-lactam plus doxycycline combinations for outpatients with comorbidities and for hospitalized patients 3
The British Thoracic Society explicitly lists amoxicillin/clavulanate 625 mg three times daily for 14 days with doxycycline 100 mg twice daily as a recommended second-line treatment for acute exacerbations of bronchiectasis caused by beta-lactamase-positive H. influenzae 1
Guidelines recommend doxycycline as an alternative to macrolides when combined with β-lactams for patients with moderate acute bacterial rhinosinusitis or recent antibiotic exposure 4

The combination of Augmentin and doxycycline is recommended for suspected polymicrobial infections requiring both gram-positive/gram-negative coverage and atypical pathogen coverage 1, 2
This combination is also recommended for respiratory infections in patients with cardiopulmonary disease or recent antibiotic exposure 1, 3
Doxycycline covers MRSA, making the combination suitable when MRSA coverage is needed alongside typical respiratory pathogens 1
The standard dosing for Augmentin is 875/125 mg orally twice daily or 625 mg three times daily for adults, and for doxycycline is 100 mg orally twice daily 1
The standard duration of treatment is 14 days for most respiratory infections 1

Doxycycline is contraindicated in pregnancy or lactation, and alternative macrolides or cephalosporins should be used instead 3, 5
Doxycycline is also contraindicated in children under 8 years of age due to the risk of tooth discoloration 5
Patients taking doxycycline should be advised to avoid sun exposure due to the risk of photosensitivity 5
Doxycycline should be taken with 8 ounces of fluid and food to minimize esophageal irritation and GI upset 5

The Infectious Diseases Society of America recommends combination therapy with Augmentin and doxycycline for outpatients with comorbidities or recent antibiotic exposure requiring coverage of both typical and atypical pathogens 6
The American College of Physicians suggests using this combination as an alternative to β-lactam plus macrolide combinations for hospitalized non-ICU patients 7, 6

The European Respiratory Society recommends a duration of 14 days for most respiratory infections (7 days minimum for uncomplicated cases) 8

The Infectious Diseases Society of America recommends using this combination when patients have cardiopulmonary comorbidities requiring outpatient treatment 6
The American College of Physicians suggests using this combination when hospitalized non-ICU patients require an alternative to macrolides or when macrolides are contraindicated or unavailable 7, 6
The Infectious Diseases Society of America advises against using this combination when patients are pregnant, breastfeeding, or under 8 years old, or when severe CAP requires ICU admission 7, 6

The Infectious Diseases Society of America recommends avoiding macrolide monotherapy in patients at risk for drug-resistant S. pneumoniae (comorbidities, recent antibiotics, age >65) 6
The Infectious Diseases Society of America suggests using high-dose amoxicillin formulations for optimal pneumococcal coverage 6